Prime Medicine, Inc. (PRME)
3.60
-0.39
(-9.77%)
USD |
NASDAQ |
Oct 12, 16:00
3.62
+0.02
(+0.56%)
After-Hours: 17:14
Prime Medicine Free Cash Flow (Quarterly) : -41.09M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -41.09M |
| March 31, 2026 | -42.92M |
| December 31, 2025 | -37.55M |
| September 30, 2025 | -35.29M |
| June 30, 2025 | -42.98M |
| March 31, 2025 | -51.28M |
| December 31, 2024 | 14.45M |
| September 30, 2024 | -27.19M |
| June 30, 2024 | -47.39M |
| March 31, 2024 | -70.03M |
| December 31, 2023 | -45.70M |
| Date | Value |
|---|---|
| September 30, 2023 | -42.08M |
| June 30, 2023 | -42.80M |
| March 31, 2023 | -43.56M |
| December 31, 2022 | -35.53M |
| September 30, 2022 | -34.89M |
| June 30, 2022 | -25.02M |
| March 31, 2022 | -52.48M |
| December 31, 2021 | -13.57M |
| September 30, 2021 | -11.43M |
| June 30, 2021 | -7.338M |
| March 31, 2021 | -5.895M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Beam Therapeutics, Inc. | -68.51M |
| Twist Bioscience Corp. | -8.648M |
| Intellia Therapeutics, Inc. | -84.92M |
| Moderna, Inc. | -563.00M |
| Q32 Bio, Inc. | -3.075M |